Proost J - Search Results

1

Chronopharmacokinetics of once daily dosed aminoglycosides in hospitalized infectious patients.

van Maarseveen E, Man WH, Proost J, Neef C, Touw D. van Maarseveen E, et al. Among authors: proost j. Int J Clin Pharm. 2015 Apr;37(2):342-7. doi: 10.1007/s11096-015-0066-7. Epub 2015 Jan 24. Int J Clin Pharm. 2015. PMID: 25616626 Free PMC article.

2

Gentamicin pharmacokinetics in preterm infants with a patent and a closed ductus arteriosus.

Touw DJ, Proost JH, Stevens R, Lafeber HN, van Weissenbruch MM. Touw DJ, et al. Among authors: proost jh. Pharm World Sci. 2001 Oct;23(5):200-4. doi: 10.1023/a:1012490704731. Pharm World Sci. 2001. PMID: 11721679

3

Optimal sampling strategy development methodology using maximum a posteriori Bayesian estimation.

van der Meer AF, Marcus MA, Touw DJ, Proost JH, Neef C. van der Meer AF, et al. Among authors: proost jh. Ther Drug Monit. 2011 Apr;33(2):133-46. doi: 10.1097/FTD.0b013e31820f40f8. Ther Drug Monit. 2011. PMID: 21383653 Review.

4

Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.

Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M. Hoekstra M, et al. Among authors: proost j. J Rheumatol. 2004 Apr;31(4):645-8. J Rheumatol. 2004. PMID: 15088287

5

Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.

Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M. Hoekstra M, et al. Among authors: proost j. J Rheumatol. 2006 Mar;33(3):481-5. Epub 2006 Jan 15. J Rheumatol. 2006. PMID: 16463431

6

Influence of erroneous patient records on population pharmacokinetic modeling and individual bayesian estimation.

van der Meer AF, Touw DJ, Marcus MA, Neef C, Proost JH. van der Meer AF, et al. Among authors: proost jh. Ther Drug Monit. 2012 Oct;34(5):526-34. doi: 10.1097/FTD.0b013e3182616937. Ther Drug Monit. 2012. PMID: 22846895

7

Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data.

Daskapan A, Tran QTD, Cattaneo D, Gervasoni C, Resnati C, Stienstra Y, Bierman WFW, Kosterink JGW, van der Werf TS, Proost JH, Alffenaar JC, Touw DJ. Daskapan A, et al. Among authors: proost jh. Ther Drug Monit. 2019 Feb;41(1):59-65. doi: 10.1097/FTD.0000000000000576. Ther Drug Monit. 2019. PMID: 30489547 Free PMC article.

8

Pharmacokinetic Modeling and Limited Sampling Strategies Based on Healthy Volunteers for Monitoring of Ertapenem in Patients with Multidrug-Resistant Tuberculosis.

van Rijn SP, Zuur MA, van Altena R, Akkerman OW, Proost JH, de Lange WC, Kerstjens HA, Touw DJ, van der Werf TS, Kosterink JG, Alffenaar JW. van Rijn SP, et al. Among authors: proost jh. Antimicrob Agents Chemother. 2017 Mar 24;61(4):e01783-16. doi: 10.1128/AAC.01783-16. Print 2017 Apr. Antimicrob Agents Chemother. 2017. PMID: 28137814 Free PMC article.

9

Dose individualization in PharmDIS-e+.

Proost JH, Punt NC. Proost JH, et al. Int J Clin Pharmacol Ther. 2003 Oct;41(10):451-8. doi: 10.5414/cpp41451. Int J Clin Pharmacol Ther. 2003. PMID: 14703950

10

Pharmacokinetic modeling of gentamicin in treatment of infective endocarditis: Model development and validation of existing models.

Gomes A, van der Wijk L, Proost JH, Sinha B, Touw DJ. Gomes A, et al. Among authors: proost jh. PLoS One. 2017 May 5;12(5):e0177324. doi: 10.1371/journal.pone.0177324. eCollection 2017. PLoS One. 2017. PMID: 28475651 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page